Published in Clin Infect Dis on January 01, 2003
Conceptual framework for understanding the bidirectional links between food insecurity and HIV/AIDS. Am J Clin Nutr (2011) 2.32
The association between food insecurity and mortality among HIV-infected individuals on HAART. J Acquir Immune Defic Syndr (2009) 2.31
Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS (2007) 1.95
Food insecurity among homeless and marginally housed individuals living with HIV/AIDS in San Francisco. AIDS Behav (2009) 1.91
Macronutrient supplementation for malnourished HIV-infected adults: a review of the evidence in resource-adequate and resource-constrained settings. Clin Infect Dis (2009) 1.75
Trends in mortality and causes of death among women with HIV in the United States: a 10-year study. J Acquir Immune Defic Syndr (2009) 1.73
Body mass index and risk of tuberculosis and death. AIDS (2010) 1.71
Obesity among patients with HIV: the latest epidemic. AIDS Patient Care STDS (2008) 1.69
C-reactive protein independently predicts HIV-related outcomes among women and children in a resource-poor setting. AIDS (2007) 1.39
Hypertension and obesity as cardiovascular risk factors among HIV seropositive patients in Western Kenya. PLoS One (2011) 1.38
Prevalence and correlates of elevated body mass index among HIV-positive and HIV-negative women in the Women's Interagency HIV Study. AIDS Patient Care STDS (2009) 1.17
An optimal body mass index range associated with improved immune reconstitution among HIV-infected adults initiating antiretroviral therapy. Clin Infect Dis (2011) 1.16
Obesity among HIV-infected persons: impact of weight on CD4 cell count. AIDS (2010) 1.14
HIV infection and obesity: where did all the wasting go? Antivir Ther (2012) 1.13
Drug use and other risk factors related to lower body mass index among HIV-infected individuals. Drug Alcohol Depend (2008) 1.13
Nutritional indicators of adverse pregnancy outcomes and mother-to-child transmission of HIV among HIV-infected women. Am J Clin Nutr (2008) 1.04
Sexual risk behaviors among HIV-infected South African men and women with their partners in a primary care program: implications for couples-based prevention. AIDS Behav (2012) 0.95
Nutrition issues in chronic drug users living with HIV infection. Addict Sci Clin Pract (2009) 0.93
Impact of weight on immune cell counts among HIV-infected persons. Clin Vaccine Immunol (2011) 0.92
Macronutrient supplementation and food prices in HIV treatment. J Nutr (2009) 0.92
Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada. AIDS Res Hum Retroviruses (2015) 0.91
Lactation-associated postpartum weight changes among HIV-infected women in Zambia. Int J Epidemiol (2010) 0.91
Body mass index and CD4+ T-lymphocyte recovery in HIV-infected men with viral suppression on antiretroviral therapy. HIV Clin Trials (2011) 0.89
High risk of obesity and weight gain for HIV-infected uninsured minorities. J Acquir Immune Defic Syndr (2014) 0.89
Body mass index, immune status, and virological control in HIV-infected men who have sex with men. J Int Assoc Provid AIDS Care (2013) 0.89
Hepatitis C virus infection is associated with insulin resistance among older adults with or at risk of HIV infection. AIDS (2007) 0.87
Dietary patterns and health and nutrition outcomes in men living with HIV infection. Am J Clin Nutr (2008) 0.85
Higher Time-Updated Body Mass Index: Association With Improved CD4+ Cell Recovery on HIV Treatment. J Acquir Immune Defic Syndr (2016) 0.85
Changes in Body Mass Index Following HAART Initiation among HIV-Infected Women in the Women's Interagency HIV Study. J AIDS Clin Res (2014) 0.82
Body mass index and the risk of incident noncommunicable diseases after starting antiretroviral therapy. HIV Med (2014) 0.80
Obesity Among HIV-Infected Adults Receiving Medical Care in the United States: Data From the Cross-Sectional Medical Monitoring Project and National Health and Nutrition Examination Survey. Medicine (Baltimore) (2015) 0.79
Relationship between Body Mass Index and Mortality in HIV-Infected HAART Users in the Women's Interagency HIV Study. PLoS One (2015) 0.79
Metabolic and anthropometric parameters contribute to ART-mediated CD4+ T cell recovery in HIV-1-infected individuals: an observational study. J Int AIDS Soc (2011) 0.78
High-nutrition biscuits to increase animal protein in diets of HIV-infected Kenyan women and their children: a study in progress. Food Nutr Bull (2014) 0.75
Incidence of Diabetes Mellitus and Obesity and the Overlap of Comorbidities in HIV+ Hispanics Initiating Antiretroviral Therapy. PLoS One (2016) 0.75
Body Mass Index, Haemoglobin, and Total Lymphocyte Count as a Surrogate for CD4 Count in Resource Limited Settings. J Biomark (2017) 0.75
Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study. J Antimicrob Chemother (2017) 0.75
CT angiography for safe discharge of patients with possible acute coronary syndromes. N Engl J Med (2012) 9.73
The prevention and treatment of missing data in clinical trials. N Engl J Med (2012) 6.92
Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA (2001) 5.52
Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med (2004) 4.30
Publication bias in editorial decision making. JAMA (2002) 3.52
A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS (2002) 3.41
Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst (2003) 2.81
The clonality of Staphylococcus aureus nasal carriage. J Infect Dis (2005) 2.39
Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load. AIDS (2010) 2.33
Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy. Clin Infect Dis (2005) 2.15
Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. J Acquir Immune Defic Syndr (2003) 2.11
Destroying the life and career of a valued physician-scientist who tried to protect us from plague: was it really necessary? Clin Infect Dis (2005) 2.06
Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS (2007) 1.95
A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users. AIDS (2007) 1.83
Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus-infected and -uninfected women. Clin Infect Dis (2001) 1.79
Comorbid conditions, treatment, and health maintenance in older persons with human immunodeficiency virus infection in New York City. Clin Infect Dis (2002) 1.73
Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study. Clin Infect Dis (2006) 1.72
Linkage to and engagement in HIV care in western Kenya: an observational study using population-based estimates from home-based counselling and testing. Lancet HIV (2015) 1.72
Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis (2003) 1.71
Technical feasibility of robot-assisted ventral hernia repair. World J Surg (2012) 1.67
Strains of Staphylococcus aureus obtained from drug-use networks are closely linked. Clin Infect Dis (2002) 1.63
HIV acquisition among women from selected areas of the United States: a cohort study. Ann Intern Med (2013) 1.59
High Prevalence of Echocardiographic Abnormalities among HIV-infected Persons in the Era of Highly Active Antiretroviral Therapy. Clin Infect Dis (2010) 1.58
Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women. J Infect Dis (2003) 1.57
The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology. Obstet Gynecol (2009) 1.56
Robotic-assisted Roux-en-Y gastric bypass: update from 2 high-volume centers. Surg Obes Relat Dis (2012) 1.55
Enhanced molecular typing of treponema pallidum: geographical distribution of strain types and association with neurosyphilis. J Infect Dis (2010) 1.51
The use of community-based modified directly observed therapy for the treatment of HIV-infected persons. J Acquir Immune Defic Syndr (2005) 1.46
Interpreting the association between HIV and bone mineral density. AIDS (2007) 1.43
Continuity of medical care and risk of incarceration in HIV-positive and high-risk HIV-negative women. J Womens Health (Larchmt) (2002) 1.43
Hypertension and obesity as cardiovascular risk factors among HIV seropositive patients in Western Kenya. PLoS One (2011) 1.38
HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women. Clin Infect Dis (2011) 1.37
Outcomes after treatment of cervical intraepithelial neoplasia among women with HIV. J Low Genit Tract Dis (2007) 1.37
Principal stratification with predictors of compliance for randomized trials with 2 active treatments. Biostatistics (2007) 1.36
Prevalence, incidence, and persistence or recurrence of trichomoniasis among human immunodeficiency virus (HIV)-positive women and among HIV-negative women at high risk for HIV infection. Clin Infect Dis (2002) 1.35
Current sexual activity and risky sexual behavior in older men with or at risk for HIV infection. AIDS Educ Prev (2007) 1.33
High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral shedding. Obstet Gynecol (2010) 1.31
Treatment outcomes of a stage 1 cognitive-behavioral trial to reduce alcohol use among human immunodeficiency virus-infected out-patients in western Kenya. Addiction (2011) 1.29
Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus. Int J Cancer (2006) 1.28
Step into Motion: a randomized trial examining the relative efficacy of Internet vs. print-based physical activity interventions. Contemp Clin Trials (2007) 1.28
Longitudinal study of mucosal Candida species colonization and candidiasis among human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis (2003) 1.28
Prevalence of and risk factors for viral infections among human immunodeficiency virus (HIV)-infected and high-risk HIV-uninfected women. J Infect Dis (2003) 1.27
Association between paired plasma and cervicovaginal lavage fluid HIV-1 RNA levels during 36 months. J Acquir Immune Defic Syndr (2006) 1.26
Psychological resources protect health: 5-year survival and immune function among HIV-infected women from four US cities. AIDS (2006) 1.24
Gender and hospitalization patterns among HIV-infected drug users before and after the availability of highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2003) 1.24
Hepatitis C infection is associated with lower lipids and high-sensitivity C-reactive protein in HIV-infected men. AIDS Patient Care STDS (2007) 1.22
Predictors of quitting and dropout among women in a clinic-based smoking cessation program. Psychol Addict Behav (2002) 1.22
Factors associated with successful referral for clinical care of drug users with chronic hepatitis C who have or are at risk for HIV infection. J Acquir Immune Defic Syndr (2004) 1.21
Rates and risk factors for condition-specific hospitalizations in HIV-infected and uninfected women. J Acquir Immune Defic Syndr (2003) 1.20
Smoking and time to clearance of human papillomavirus infection in HIV-seropositive and HIV-seronegative women. Am J Epidemiol (2006) 1.20
The association of hepatitis C prevalence, activity, and genotype with HIV infection in a cohort of New York City drug users. J Acquir Immune Defic Syndr (2003) 1.19
Progression of carotid intima-media thickness in a contemporary human immunodeficiency virus cohort. Clin Infect Dis (2011) 1.18
Estimating causal treatment effects from longitudinal HIV natural history studies using marginal structural models. Biometrics (2003) 1.17
Human papillomavirus capsid antibody response to natural infection and risk of subsequent HPV infection in HIV-positive and HIV-negative women. Cancer Epidemiol Biomarkers Prev (2005) 1.17
A multicenter study of bacterial vaginosis in women with or at risk for human immunodeficiency virus infection. Infect Dis Obstet Gynecol (2001) 1.17
Sequence quality analysis tool for HIV type 1 protease and reverse transcriptase. AIDS Res Hum Retroviruses (2011) 1.16
Crack cocaine use and other risk factors for tuberculin positivity in drug users. Clin Infect Dis (2002) 1.14
Changes in total lymphocyte count as a surrogate for changes in CD4 count following initiation of HAART: implications for monitoring in resource-limited settings. J Acquir Immune Defic Syndr (2004) 1.13
Association of hepatitis C infection and antiretroviral use with diabetes mellitus in drug users. Clin Infect Dis (2003) 1.12
Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection. Am J Obstet Gynecol (2002) 1.12
Scabies and pediculosis pubis: an update of treatment regimens and general review. Clin Infect Dis (2002) 1.10
Multi-detector row CT angiography of the brain at various kilovoltage settings. Radiology (2004) 1.09
Persistence of inconsistent condom use: relation to abuse history and HIV serostatus. AIDS Behav (2004) 1.07
Responding to a community outbreak of syphilis by targeting sex partner meeting location: an example of a risk-space intervention. Sex Transm Dis (2003) 1.07
Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for human immunodeficiency virus. Obstet Gynecol (2006) 1.06
Prospective study of bone mineral density changes in aging men with or at risk for HIV infection. AIDS (2010) 1.06
Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection. N Engl J Med (2001) 1.06
Influence of sex hormones, HIV status, and concomitant sexually transmitted infection on cervicovaginal inflammation. J Infect Dis (2004) 1.04
Changing Epidemiology of Syphilis and Its Persistent Relationship with HIV. Curr Infect Dis Rep (2004) 1.03
Lower syringe sharing and re-use after syringe legalization in Rhode Island. Drug Alcohol Depend (2007) 1.03
Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis infections in men with nongonococcal urethritis: predictors and persistence after therapy. J Infect Dis (2012) 1.02
Incidence of violence against HIV-infected and uninfected women: findings from the HIV Epidemiology Research (HER) study. J Urban Health (2002) 1.02
Gender differences in illicit substance use among middle-aged drug users with or at risk for HIV infection. Clin Infect Dis (2006) 1.02
Progressive regression of left ventricular hypertrophy two years after bariatric surgery. Am J Med (2010) 1.01
Longitudinal association of alcohol use with HIV disease progression and psychological health of women with HIV. AIDS Care (2009) 1.00
Use of highly active antiretroviral therapy in HIV-infected women: impact of HIV specialist care. J Acquir Immune Defic Syndr (2002) 1.00